12 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

NELLCOR PURITAN BENNETT, 740 VENTILATOR SYSTEM

FDA 510(k)
FDA Class 2 ·Anesthesiology

Armada

FDA UDI
Nuvasive, Inc.·00887517394460·ARM16S Screw, 4.5x40mm Fixed

MEGA PLUS MIS SPINE SYSTEM

FDA UDI
BK MEDITECH CO.,LTD.·08809665583246·MIS Cannulated Screw, Ø4.5 x 40mm, Ø6.0mm Rod

VIDEO SYSTEM INTERFACE MODELS

FDA 510(k)
FDA Class 2 ·Radiology

PLAK VAK - PV-10

FDA 510(k)
FDA Class 1 ·Dental

SPRINT QUATTRO SECURE S

FDA Adverse Event
Injury ·MPRI·Product code LWS·February 15, 2013

PRECISION TEST STRIPS

FDA Adverse Event
Malfunction ·ABBOTT DIABETES CARE, INC. USA·Product code NBW·January 20, 2011

G4 PLATINUM CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code MDS·July 29, 2014

BA102

FDA Adverse Event
Malfunction ·NAKANISHI INC.·Product code EGS·March 31, 2016

BA105

FDA Adverse Event
Malfunction ·NAKANISHI INC.·Product code EGS·March 28, 2016

NSK

FDA Adverse Event
Injury ·NAKANISHI INC.·Product code EGS·August 29, 2017

Anthem Model Numbers: PM3210, PM3212; Allure/Relieve Model Numbers: PM3222, PM3242, PM3262, PM3542, PM3224, PM3244 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·October 25, 2017